Taylor Morrison
TMHC
$71.93
+0.39%
Taylor Morrison Home Corporation is a prominent American residential construction company that designs, builds, and sells single and multi-family homes, primarily focusing on entry-level, move-up, and resort lifestyle buyers across high-growth markets. The company operates as a major national homebuilder with a distinct competitive identity through its development of lifestyle communities and a diversified geographic footprint across its East, Central, and West segments. The current investor narrative is overwhelmingly dominated by Berkshire Hathaway's recent all-cash acquisition of the company, which has established a new valuation floor for the sector and sparked intense debate about the strategic bet on a housing market recovery and the implications of new leadership at Berkshire deploying capital.…
TMHC
Taylor Morrison
$71.93
Related headlines
TMHC 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Taylor Morrison's 12-month outlook, with a consensus price target around $93.51 and implied upside of +30.0% versus the current price.
Average Target
$93.51
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$58 - $94
Analyst target range
Analyst coverage for TMHC appears limited, with data indicating only 5 covering analysts, and the provided data points focus on estimated future financials rather than price targets or ratings. The dataset lacks a consensus recommendation, average target price, and target price range, which are essential for this section. Therefore, insufficient analyst coverage data is available to form a consensus view or calculate implied upside/downside; this limited coverage prior to the acquisition announcement was typical for many mid-cap homebuilders and can contribute to higher volatility and less efficient price discovery, a dynamic fundamentally altered by Berkshire Hathaway's takeover offer which now sets the definitive price.
Bulls vs Bears: TMHC Investment Factors
The evidence strongly favors the bull case, but it is a specialized, event-driven bull case. The most compelling bullish factor is the concrete, all-cash offer from Berkshire Hathaway at a 24% premium, which provides a high-probability exit near current prices. The most significant bearish risk is the binary nature of the investment: if the deal fails, the stock would likely plummet back toward its pre-deal valuation based on its trailing P/E of ~7.5x. The single most important tension in the investment debate is no longer about TMHC's standalone fundamentals, but about the certainty and timing of the acquisition closing. The bear side's argument hinges entirely on deal risk, while the bull side's argument rests on the high likelihood of Berkshire completing the transaction.
Bullish
- Berkshire Hathaway Acquisition at 24% Premium: Berkshire Hathaway's all-cash acquisition establishes a definitive valuation floor and provides immediate liquidity for shareholders at a significant premium to the pre-announcement price. This is a classic Buffett-style bet on a cyclical recovery, signaling deep value and strategic importance.
- Strong Technical Momentum Post-Deal: The stock surged 29.72% over the past month, decisively breaking out from its previous trading range and now consolidating near the 52-week high of $72.50. This powerful move, with a 24.92% gain over three months, indicates the market is pricing in the deal's certainty and its sector-wide implications.
- Conservative Balance Sheet & Strong Liquidity: A debt-to-equity ratio of 0.38 and a current ratio of 6.24 indicate a fortress-like balance sheet with minimal leverage and ample short-term liquidity. This financial strength made the company an attractive, low-risk acquisition target for Berkshire and provides operational resilience in a cyclical industry.
- Attractive Trailing Valuation Metrics: Prior to the deal, the stock traded at a trailing P/E of 7.45x and a P/S of 0.72x, which are low absolute multiples. The forward P/E of 11.15x, based on an estimated EPS of $6.53, suggests the market was anticipating earnings growth even before the strategic premium was applied.
Bearish
- Deal Completion is Sole Catalyst: The investment thesis is now entirely dependent on the successful closure of the Berkshire Hathaway acquisition. With the stock trading near the implied deal price, there is minimal fundamental upside remaining, and any deal-breaking risk would likely cause a severe price collapse.
- Extreme Volatility and High Beta: The stock's beta of 1.484 means it is roughly 50% more volatile than the broader market. This high volatility, evidenced by a 23.8% max drawdown in the provided data, presents significant price risk for remaining shareholders during the deal's pendency, especially if broader market sentiment sours.
- Limited Independent Analyst Coverage: Only 5 analysts cover the stock, and traditional price targets are now obsolete. This limited coverage historically contributed to less efficient price discovery and higher volatility, a dynamic that persists but is now overshadowed by the binary deal outcome.
- Cyclical Industry Headwinds Persist: As a residential construction company, TMHC remains exposed to interest rate sensitivity, economic cycles, and housing affordability challenges. Berkshire's bet is on the long-term cycle, but short-term operational pressures could persist until the deal closes.
TMHC Technical Analysis
The stock is in a pronounced, sustained uptrend, evidenced by a 24.66% gain over the past year, and is currently trading near the top of its 52-week range, specifically at approximately 99% of the range between the 52-week low of $54.15 and high of $72.50, indicating strong momentum but also potential overextension. Recent short-term momentum is exceptionally strong and accelerating, with a 29.72% surge over the past month and a 24.92% gain over three months, significantly outpacing the broader market's 0.74% and 15.14% returns over the same periods, respectively, which suggests the stock is reacting to a major, company-specific catalyst rather than broader market trends. Key technical support is anchored at the 52-week low of $54.15, while immediate resistance sits at the 52-week high of $72.50; a confirmed breakout above $72.50 would signal a continuation of the powerful uptrend ignited by the acquisition news, while the stock's high beta of 1.484 indicates it is roughly 50% more volatile than the market, a critical factor for risk assessment given the recent parabolic move.
Beta
1.48
1.48x market volatility
Max Drawdown
-23.8%
Largest decline past year
52-Week Range
$54-$73
Price range past year
Annual Return
+17.0%
Cumulative gain past year
| Period | TMHC Return | S&P 500 |
|---|---|---|
| 1m | +24.0% | -1.7% |
| 3m | +22.1% | +13.7% |
| 6m | +20.4% | +6.2% |
| 1y | +17.0% | +20.8% |
| ytd | +22.3% | +7.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TMHC Fundamental Analysis
Data not available for a detailed quarterly revenue trajectory, YoY growth rates, or segment performance, preventing a granular analysis of the company's growth drivers and trends leading up to the acquisition announcement. Similarly, specific profitability metrics like recent net income and gross margin figures are not provided in the required quarterly format, though the trailing net margin of 9.63% and gross margin of 23.03% from valuation data indicate the company was profitable with industry-typical margins prior to the deal. The balance sheet and cash flow health cannot be assessed from the provided data as the quarterly financials, cash flow statements, and financial ratios arrays are empty, though the debt-to-equity ratio of 0.38 and current ratio of 6.24 from key metrics suggest a conservative capital structure and strong short-term liquidity at the last snapshot.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TMHC Overvalued?
Given the company's profitability indicated by a positive net margin, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 7.45x and a forward PE of 11.15x; the higher forward multiple implies the market expects earnings growth, though the specific forward EPS estimate of $6.53 is not directly comparable to the trailing EPS of $0.13 without annualization context. Peer comparison data for industry average multiples is not available in the provided dataset, so a relative premium or discount to the sector cannot be quantified. Historical context for the stock's own valuation range (e.g., historical PE bands) is also unavailable, preventing an assessment of whether the current multiple is at a historical extreme, though the acquisition price likely sets a new benchmark.
PE
7.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
6.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is now deal completion risk, not operational performance. However, pre-deal financials showed a robust profile with a low debt-to-equity ratio of 0.38 and strong current ratio of 6.24, mitigating traditional balance sheet concerns. The trailing net margin of 9.63% indicates profitability, but the business remains cyclically exposed to housing demand and input costs. The lack of detailed quarterly data prevents a granular assessment of recent revenue or margin trends, adding a layer of uncertainty about the underlying business momentum heading into the deal.
Market & Competitive Risks: The paramount market risk is a collapse in the acquisition premium if the deal is terminated or faces regulatory hurdles. The stock's high beta of 1.484 signifies it will amplify any negative market moves, increasing volatility risk during the holding period. Competitively, the deal itself has reset sector valuations, but TMHC's standalone competitive position in a fragmented industry was likely a factor in its attractive valuation (P/S of 0.72) to an acquirer like Berkshire seeking a strategic platform.
Worst-Case Scenario: The worst-case scenario is the Berkshire Hathaway acquisition falling through due to regulatory intervention, a material adverse change in TMHC's business, or a decision by Berkshire to walk away. In this scenario, the stock would likely crash, erasing the entire deal premium. A realistic downside target would be a return to its pre-deal trading range, anchored by the 52-week low of $54.15. From the current price near $71.60, this implies a potential loss of approximately -24%. Given the stock's high volatility, a drop exceeding 30% in a deal-break scenario is plausible.